Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

126.06
Delayed Data
As of 3:59pm ET
 +18.50 / +17.20%
Today’s Change
35.83
Today|||52-Week Range
126.47
+81.54%
Year-to-Date
Jim Cramer's 'Mad Money' Recap: Why Tonight's Debate Doesn't Really Matter
7:23pm / TheStreet.com - Paid Partner Content
Why GW Pharmaceuticals Stock Is Surging Higher Today
10:46am / MotleyFool.com - Paid Partner Content
This Marijuana Stock Is on a Roll
7:22pm / MotleyFool.com - Paid Partner Content
Masimo Foundation Co-Finds the United for Oxygen Alliance
10:40am / Zacks.com - Paid Partner Content
Why Array BioPharma, Chemtura, and GW Pharmaceuticals Jumped Today
6:04pm / MotleyFool.com - Paid Partner Content
Bruker-3M Company Expand FFPE Tissue Processing License
9:53am / Zacks.com - Paid Partner Content
GW Pharmaceuticals (GWPH) Stock Soars on Positive Trial Results, Piper Jaffray Bullis...
12:57pm / TheStreet.com - Paid Partner Content
Varian Medical Hits 52-Week High; Oncology Prospects Bright
Sep 23 / Zacks.com - Paid Partner Content
AMN Healthcare Services (AHS) Prices Senior Notes Offering
10:51am / Zacks.com - Paid Partner Content
Becton (BDX) to Expand Syringe Capacity at Holdrege Facility
Sep 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close107.56
Today’s open120.51
Day’s range119.27 - 126.47
Volume3,348,601
Average volume (3 months)604,431
Market cap$2.7B
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)-140.06%
Earnings growth (this year)-27.74%
Earnings growth (next 5 years)-48.37%
Revenue growth (last year)-11.81%
P/E ratio--
Price/Sales42.63
Price/Book6.30

Competitors

 Today’s
change
Today’s
% change
SRPTSarepta Therapeutics...+1.83+3.16%
----
PBHPrestige Brands Hold...-0.50-1.03%
MDCOMedicines Co-0.64-1.58%
Data as of 4:02pm ET, 09/26/2016

Financials

Next reporting dateNovember 15, 2016
EPS forecast (this quarter)-$1.40
Annual revenue (last year)$44.0M
Annual profit (last year)-$68.7M
Net profit margin-156.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer &
Executive Director
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts

Search for Jobs